arrow2 Comments
  1. […] friend and patent law expert, Stephen Albainy-Jenei reviewed this decision in a May 19 post, so I refer you to that well-written comment for details. I would only add that, although the […]

  2. […] This post was mentioned on Twitter by IPNewsOfInterest, Didier Jammes. Didier Jammes said: Patent Baristas » When It Comes to Patent Term Extensions, An Enantiomer is a Different Drug From Racemate […]

Mobile Theme